Cogni Labs Limited
About Cogni Labs Limited
Data last updated:
Cogni Labs Limited is a public limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21000DL2016PLC291734.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Ashutosh Goel and Naresh Kumar Goel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. – 8 Room No. – 3 First Floor, Printing Press Area Wazirpur, Delhi, India – 110035.
As per the financials filed for FY 2025, the company reported a revenue of ₹89,387, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹22,121 (net margin 24.7%) and EBITDA of ₹26,893 (EBITDA margin 30.1%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Cogni Labs has one previous CIN (Corporate Identification Number): U24233DL2016PLC291734. The current CIN is U21000DL2016PLC291734, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21000DL2016PLC291734 | Current |
| U24233DL2016PLC291734 | Previous |
Contact details
Cogni Labs Limited's registered office is in Delhi, Delhi.
- Registered AddressPlot No. – 8 Room No. – 3 First Floor, Printing Press Area Wazirpur, Delhi, India – 110035
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Cogni Labs Limited
FY 2025 filings availableCogni Labs Limited reported revenue of ₹89,387 (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 21% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 439% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26,893 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22,121 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 30.1% | ||||
| Net Profit Margin | 24.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cogni Labs Limited, buy the company report.
Board of directors of Cogni Labs Limited
Cogni Labs has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashutosh Goel Also directs: Cogni Pharmaceuticals LLP, Gangesh Renewable Energy LLP, Gangesh Reality LLP and 4 more | Director | 15 Dec 2016 | 9 Years 10 Months | Current |
| Naresh Kumar Goel Also directs: Sun Medilab LLP, Cogni Pharmaceuticals LLP, Warner India Lifesciences Limited and 5 more | Director | 25 Feb 2016 | 10 Years 7 Months | Current |
| Mayank Goel Also directs: Cogni Pharmaceuticals LLP, Gangesh Renewable Energy LLP, Gangesh Reality LLP and 5 more | Director | 15 Dec 2016 | 9 Years 10 Months | Current |
| Pranav Trikha Also directs: Meeracle Apparel LLP, P & U Retail LLP | Director | 01 Sep 2025 | 1 Years 1 Months | Current |
Peer comparison
Cogni Labs Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Panaaya Pharma Private Limited | ₹91,650 (FY 2025) | -67.0% | Secunderabad, Telangana, India | |||
| Biopeak Lifescience Private Limited | ₹91,218 (FY 2025) | 12.0% | Mumbai, Maharashtra, India | |||
| Grace N Glory Medical Private Limited | ₹90,733 (FY 2025) | -97.0% | Kolhapur, Maharashtra, India | |||
| Vancure Pharma Private Limited | ₹90,594 (FY 2021) | 192.0% | Unchahar, Uttar Pradesh, India | |||
| CPD Pharma Private Limited | ₹90,000 (FY 2025) | -100.0% | Chennai, Tamil Nadu, India | |||
| Cogni Labs Limitedthis company | ₹89,387 (FY 2025) | ₹22,121 | 24.7% | 21.0% | Delhi, India | |
| Bismed Health Care Private Limited | ₹87,865 (FY 2025) | -5.0% | Muzaffarpur, Bihar, India | |||
| Mercure Pharmaceuticals (OPC) Private Limited | ₹85,541 (FY 2025) | 4.0% | Indore, Madhya Pradesh, India | |||
| Rising Life Science Private Limited | ₹85,000 (FY 2021) | -46.0% | Vadodara, Gujarat, India | |||
| Archana Pharmaceuticals Private Limited | ₹84,150 (FY 2024) | -45.0% | New Delhi, Delhi, India | |||
| RGM Trading Private Limited | ₹84,000 (FY 2024) | -30.0% | Thane, Maharashtra, India |
To see the full peer comparison of Cogni Labs Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cogni Labs Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cogni Labs Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cogni Labs Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cogni Labs Limited has 8 board changes on record since 2016: 4 appointments and 4 cessations. The latest: Pranav Trikha was appointed as Director on 01 Sep 2025.
Frequently asked questions
Cogni Labs is an active public limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 February 2016 (10+ years old) and is registered under CIN U21000DL2016PLC291734.
Cogni Labs has 4 current directors:
- Ashutosh Goel - Director
- Naresh Kumar Goel - Director
- Mayank Goel - Director
- Pranav Trikha - Director
The latest financial statements of Cogni Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Cogni Labs is U21000DL2016PLC291734. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cogni Labs was incorporated on 25 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Cogni Labs by revenue are Panaaya Pharma Private Limited, Biopeak Lifescience Private Limited, Grace N Glory Medical Private Limited, Vancure Pharma Private Limited, CPD Pharma Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Pranav Trikha was appointed as Director on 01 Sep 2025. Ashutosh Goel ceased to be Additional Director on 25 Sep 2017. Mayank Goel ceased to be Additional Director on 25 Sep 2017. Cogni Labs has 8 board changes on record in total.
The registered office of Cogni Labs is at Plot No. – 8 Room No. – 3 First Floor, Printing Press Area Wazirpur, Delhi, India – 110035.
Cogni Labs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Cogni Labs is compliant as of 30 August 2026. The company is actively filing with the Registrar of Companies.
Cogni Labs can be reached at its registered office: Plot No. – 8 Room No. – 3 First Floor, Printing Press Area Wazirpur, Delhi, India – 110035.